Is it time for you to begin screening for colorectal cancer? Screening looks for signs of cancer in someone who doesn’t have any symptoms. The idea is that by catching cancer early, before it spreads, ...

Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Direct-to-consumer advertising in oncology: A content analysis of print media No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting.

At-home cancer tests are a great way to learn key information about your health without having to visit the doctor in person. This option is good for patients who dont have time to go to the doctors ...

New research emphasizes the importance of scheduling a colonoscopy as soon as possible after an abnormal stool blood test. Patients who received colonoscopies more than 13 months after abnormal tests ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Patients with acute coronary syndrome had similar outcomes for all-cause mortality and bleeding ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Headlines are meant to grab your attention. So, if you read ...